首页> 外文学位 >The effects of black raspberry extract on UVB-induced inflammation and carcinogenesis.
【24h】

The effects of black raspberry extract on UVB-induced inflammation and carcinogenesis.

机译:黑树莓提取物对UVB诱导的炎症和致癌作用的影响。

获取原文
获取原文并翻译 | 示例

摘要

Non-melanoma skin cancers (NMSCs), especially squamous cell carcinoma (SCC), are a significant problem in the general population, and a deadly one among immunosuppressed populations. Nearly a third of transplant patients die from aggressive SCCs, and the risk for development increases as the length of time under immunosuppression increases. It is not yet fully understood how immunosuppression impacts UVB-induced inflammation and carcinogenesis. In Chapter 2, we determine the impact of different immunosuppressive drugs on UVB-induced inflammation and carcinogenesis. We found that cyclosporine (CsA) exacerbates all markers of inflammation and carcinogenesis, including angiogenesis. Mycophenolate mofetil (MMF), when co-administered with CsA reduced the markers of inflammation and carcinogenesis to near vehicle levels. Choice of immunosuppression, therefore, plays a role in the development of SCC in transplant patients.;The changes wrought in keratinocytes by the change from normal cell to malignant cell are poorly understood. Understanding the changes in cytokine and chemokine expression, as well as the changes in programmed cell death pathways would give new avenues for treatment and prevention. To expand the knowledge of these changes, we used an in vitro system of normal (JB6) and pre-malignant (308) keratinocytes in the presence and absence of UVB (Chapter 3). We found that 308 cells produce more inflammatory cytokines than JB6 cells, and 308 cells have an altered expression of autophagy proteins. These changes may illustrate the steps necessary for malignant transformation.;Preventing the transformation of normal cells would be a life saver to the general population. The use of a treatment that would not interfere with immunosuppressive medications would be a boon to transplant patients. To address both of these we developed a post-UVB-exposure treatment derived from black raspberries (BRE). In Chapter 4, we explore the efficacy of BRE in the prevention of UVB-induced inflammation and carcinogenesis. BRE is able to reduce all markers of inflammation, with the exception of neutrophil infiltration. BRE is also able to reduce carcinogenesis, possibly through a reduction in tumor-infiltrating regulatory T cells.;In Chapter 5, we further explored the mechanisms behind the extract's ability to reduce the effects of UVB exposure. We again used the in vitro system of JB6 and 308 cells in the absence or presence of UVB. BRE was able to alter the cytokine and chemokine production of both cells lines whether UVB was used or not, but the results did not always match in vivo results. BRE also was able to return the expression of autophagy proteins in 308 cells more to a pattern resembling JB6 cells. We also used acutely exposed dorsal skin and UVB-induced tumors in attempt to confirm the in vitro findings. The in vitro and in vivo data correlated well.
机译:非黑素瘤皮肤癌(NMSCs),尤其是鳞状细胞癌(SCC)在普通人群中是一个重大问题,在免疫抑制人群中是致命的。将近三分之一的移植患者死于侵袭性SCC,并且随着免疫抑制时间的延长,发育的风险也随之增加。尚未完全了解免疫抑制如何影响UVB诱导的炎症和致癌作用。在第2章中,我们确定了不同的免疫抑制药物对UVB诱导的炎症和致癌作用的影响。我们发现环孢素(CsA)加剧了炎症和癌变,包括血管生成的所有标记。霉酚酸酯(MMF)与CsA并用时,可将炎症和致癌标志物降低至接近媒介物水平。因此,免疫抑制的选择在移植患者的SCC的发展中起着重要作用。;人们对由正常细胞向恶性细胞变化而引起的角质形成细胞变化的了解很少。了解细胞因子和趋化因子表达的变化,以及程序性细胞死亡途径的变化,将为治疗和预防提供新的途径。为了扩展对这些变化的了解,我们使用了存在和不存在UVB的体外正常(JB6)和恶性前(308)角质形成细胞的系统(第3章)。我们发现308细胞比JB6细胞产生更多的炎性细胞因子,并且308细胞的自噬蛋白表达改变。这些变化可能说明了恶性转化所必需的步骤。防止正常细胞的转化将为一般人群节省生命。使用不干扰免疫抑制药物的治疗方法将为移植患者带来福音。为了解决这两个问题,我们开发了源自​​黑莓(BRE)的UVB暴露后处理。在第4章中,我们探讨了BRE预防UVB诱导的炎症和癌变的功效。除中性粒细胞浸润外,BRE能够减轻所有炎症标志。 BRE还可能通过减少肿瘤浸润的调节性T细胞来减少癌变。在第5章中,我们进一步探讨了提取物减少UVB暴露影响的机制。在不存在或存在UVB的情况下,我们再次使用JB6和308细胞的体外系统。无论是否使用UVB,BRE都能改变两种细胞系的细胞因子和趋化因子产生,但结果并不总是与体内结果相符。 BRE还能够使308细胞中的自噬蛋白的表达更多地返回类似于JB6细胞的模式。我们还使用了急性暴露的背部皮肤和UVB诱导的肿瘤,试图证实体外发现。体外和体内数据相关性很好。

著录项

  • 作者

    Duncan, F. Jason.;

  • 作者单位

    The Ohio State University.;

  • 授予单位 The Ohio State University.;
  • 学科 Health Sciences Immunology.;Health Sciences Oncology.
  • 学位 Ph.D.
  • 年度 2009
  • 页码 158 p.
  • 总页数 158
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号